Preferred Label : raltitrexed;

MeSH note : RN & structure given in first source; assumed raltitrexed is a SY based on reference to Eur J Cancer 1995;31A:1945-54 in article;

CISMeF synonym : D1694; ICI D1694; ZD 1694; tomudex; AstraZeneca brand of raltitrexed; arkomédika brand of raltitrexed; zeneca brand of raltitrexed;

MeSH synonym : N-(5-(N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid;

MeSH hyponym : ICI-D1694; ZD1694; ZD-1694; D 1694; D-1694;

MeSH Related Number : 112887-68-0;

Registry Number MeSH : 112887-68-0;

Is substance : O;

UNII : FCB9EGG971;

InChIKey : IVTVGDXNLFLDRM-HNNXBMFYSA-N;

Details


Main resources

You can consult :


http://www.has-sante.fr/portail/jcms/c_1758545/fr/tomudex
2014
false
false
false
France
French
evaluation of the transparency committee
colorectal neoplasms
neoplasm metastasis
treatment outcome
raltitrexed
raltitrexed
raltitrexed
antimetabolites, antineoplastic
antimetabolites, antineoplastic
infusions, intravenous
disease progression
adult
survival analysis
raltitrexed
antimetabolites, antineoplastic
clinical trials as topic
quinazolines
thiophenes
quinazolines
thiophenes
quinazolines
thiophenes

---
Nous contacter.
14/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.